Akeso’s lung cancer drug reduces death risk by 34%, marking the first Chinese drug at ASCO’s top stage in 61 years

Narrative Intelligence Brief

This article was published by The Next Web, a source frequently categorized with a lean left bias based in Netherlands. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The Next Web, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.